SLNO · Soleno Therapeutics Inc
$53.01
+0.00 (+0.00%)
At close · May 18
Market Cap
$2.76B
Shares
52.12M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2024-07-01 | $150,000,000 | — | — | — | 10-Q , filed 2026-05-07 |
Cash spent on buybacks by quarter
Cash deployed each quarter.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source | ||
|---|---|---|---|---|
| 2026-03-31 YTD | $4,000 | 10-Q, filed 2026-05-07 | ||
| 2025-12-31 | $100,146,000 | 10-K, filed 2026-02-25 | ||